Cindy Lamerson, MD
NPI 1699763201 · Dermatology Physician · Reno, NV
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Cindy Lamerson, MD is a Dermatology Physician provider in Reno, NV (NPI 1699763201).
Provider details
- NPI number
- 1699763201
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 8902 (NV)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
6,075 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,469 | $6 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,207 | $119 |
| Biopsy of Related Skin Growth, First Growth11102 | 606 | $85 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 442 | $47 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 398 | $47 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 108 | 48 |
| Mupirocin | 104 | 78 |
| Triamcinolone Acetonide | 67 | 41 |
| Hydroxyzine Hcl | 53 | 13 |
| Doxycycline Hyclate | 53 | 19 |
| Valacyclovir Hclbrand: Valacyclovir | 36 | 22 |
| Cephalexin | 34 | 30 |
| Dupilumabbrand: Dupixent Syringe |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,984 across 85 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-10-07
- Last updated
- 2015-05-26
Frequently asked questions
- What is Cindy Lamerson's NPI number?
- Cindy Lamerson's National Provider Identifier (NPI) is 1699763201, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Cindy Lamerson's specialty?
- Cindy Lamerson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Cindy Lamerson located?
- Cindy Lamerson's practice location on file with NPPES is 650 Sierra Rose Dr, Reno, NV 89511-2081.
- What is Cindy Lamerson's phone number?
- The practice phone number listed in the NPPES registry for Cindy Lamerson is (775) 827-8100.
- Does Cindy Lamerson accept Medicare?
- Cindy Lamerson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Cindy Lamerson's NPI active?
- Yes — Cindy Lamerson's NPI (1699763201) is active in the NPPES registry as of the last update on 2015-05-26.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.